These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 26425376)
21. Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings. Wada S; Suzuki T; Kitazume K; Fujita A; Shimizu S Int J Hematol; 2018 Jul; 108(1):112-117. PubMed ID: 29218495 [TBL] [Abstract][Full Text] [Related]
22. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study. Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284 [TBL] [Abstract][Full Text] [Related]
23. [A Case of Severe Chronic Active Epstein-Barr Virus Infection with Aplastic Anemia and Hepatitis]. Lee JI; Lee SW; Han NI; Ro SM; Noh YS; Jang JW; Bae SH; Choi JY; Yoon SK Korean J Gastroenterol; 2016 Jan; 67(1):39-43. PubMed ID: 26809631 [TBL] [Abstract][Full Text] [Related]
24. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia]. Xie XT; He W; Shi W; Zhou XX; Qiao XH Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia. Calistri E; Tiribelli M; Battista M; Michelutti A; Corbellino M; Viale P; Fanin R; Damiani D Am J Hematol; 2006 May; 81(5):355-7. PubMed ID: 16628717 [TBL] [Abstract][Full Text] [Related]
26. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia. Dorr V; Doolittle G; Woodroof J Am J Hematol; 1996 Jun; 52(2):108-13. PubMed ID: 8638630 [TBL] [Abstract][Full Text] [Related]
27. [Combination of rabbit antithymocyte globulin plus cyclosporin A as first-line immunosuppressive therapy for the childhood with severe aplastic anemia.]. Liu LY; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):749-53. PubMed ID: 20137310 [TBL] [Abstract][Full Text] [Related]
28. Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia. Xie X; Shi W; Zhou X; Shao Y; Qiao X Exp Hematol; 2014 Jun; 42(6):431-8. PubMed ID: 24582815 [TBL] [Abstract][Full Text] [Related]
29. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980 [TBL] [Abstract][Full Text] [Related]
30. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia. Peffault de Latour R; Tabrizi R; Marcais A; Leblanc T; Lamy T; Mohty M; Tavitian S; Jubert C; Pasquet M; Galambrun C; Nguyen S; Cahn JY; Braun T; Deconinck E; Bay JO; Sicre de Fontbrune F; Barraco F; Socié G Am J Hematol; 2018 May; 93(5):635-642. PubMed ID: 29377260 [TBL] [Abstract][Full Text] [Related]
32. [Quantitative monitoring of mononucleated cell Epstein-Barr virus (EBV)-DNA for predicting EBV associated lymphoproliferative disorders after stem cell transplantation.]. Wang LH; Ren HY; Sun YH; Qiu ZX; Cen XN; Ou JP; Xu WL; Wang MJ; Wang WS; Li Y; Dong YJ; Yin Y; Liang ZY Zhonghua Xue Ye Xue Za Zhi; 2010 Feb; 31(2):73-6. PubMed ID: 20302791 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of aplastic anemia with anti-thymocyte globulin and cyclosporine]. Ohnishi S; Nakagawa M; Kobayashi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Kasai M Rinsho Ketsueki; 1998 Sep; 39(9):640-4. PubMed ID: 9796396 [TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine. Fang JP; Xu HG; Huang SL; Chen C; Huang K Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653 [TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr-virus-associated hepatitis with aplastic anemia: A case report. Zhang WJ; Wu LQ; Wang J; Lin SY; Wang B World J Clin Cases; 2022 Aug; 10(23):8242-8248. PubMed ID: 36159516 [TBL] [Abstract][Full Text] [Related]
37. Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child. Choi IS; Kim HK; Han DK; Baek HJ; Jang HI; Kim CJ; Kook H Korean J Pediatr; 2015 Jul; 58(7):267-9. PubMed ID: 26300942 [TBL] [Abstract][Full Text] [Related]
38. Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic anemia. Song MK; Chung JS; Joo YD; Lee GW; Hong J; Park SH; Shin HJ Leuk Res; 2015 Mar; 39(3):284-9. PubMed ID: 25563075 [TBL] [Abstract][Full Text] [Related]
39. Prolonged renal failure secondary to antithymocyte globulin treatment in severe aplastic anemia. Barakat RK; Schmolck JP; Finkel KW; Foringer JR Ann Pharmacother; 2007 May; 41(5):895-8. PubMed ID: 17426071 [TBL] [Abstract][Full Text] [Related]
40. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies. Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]